Saksena N K, Ge Y C, Wang B, Xiang S H, Dwyer D E, Randle C, Palasanthiran P, Ziegler J, Cunningham A L
Retroviral Genetics Laboratory, Westmead Institutes for Health Research, Westmead Hospital, NSW, Sydney, Australia.
Ann Acad Med Singap. 1996 Nov;25(6):848-54.
We describe a long-term non-progressive injecting drug user (IDU) who was infected with human immunodeficiency virus type-1 (HIV-1) in 1984, and has survived with stable CD4+ T-cell counts (> 800/microliters blood) without any acquired immune deficiency syndrome (AIDS) related illness. With a goal to investigate the molecular nature of HIV-1 strains infecting this patient, we amplified the nef and vpr genes directly from the fresh uncultured peripheral blood mononuclear cells (PBMCs), and carried out co-culture studies. Sequence analysis of the nef gene (from 1994 samples) showed no deletions (as has been previously reported) expected for a 7 base pair duplication at the C-terminus which prematurely terminated the nef reading frame, whereas even after repeated attempts the nef gene could not be amplified from the 1992 PBMC samples. In contrast, the vpr gene (from 1992 and 1994 samples) revealed two distinct quasispecies with no apparent defects. We observed five amino acid substitutions, between residues 83-90, at the C-terminus which has been recently implicated in G2 cell cycle arrest as an early step to HIV-1 infection. In the light of recent evidence on the role of nef gene defects/attenuations in long-term survival of HIV-1 infected patients, it may be that the nef gene defect created by gene duplication, which eliminated the cysteine-206 crucial in disulfide bond formation, may play a role in chronic HIV-1 infection in this patient. These data further suggest that deletions in the nef gene may not be the only reason for long-term non-progression of HIV-1 infection in some individuals, but the gene defects like duplication and subtle mutations in the functional motifs of both nef and vpr genes may confer similar protection in HIV-1 infected patients surviving for longer periods of time with stable CD4 counts.
我们描述了一名长期非进展性注射吸毒者(IDU),其于1984年感染了1型人类免疫缺陷病毒(HIV-1),并在CD4 + T细胞计数稳定(> 800/微升血液)的情况下存活,未出现任何获得性免疫缺陷综合征(AIDS)相关疾病。为了研究感染该患者的HIV-1毒株的分子特性,我们直接从新鲜未培养的外周血单核细胞(PBMC)中扩增nef和vpr基因,并进行了共培养研究。对nef基因(来自1994年样本)的序列分析显示,在C末端没有预期的7个碱基对重复缺失(如先前报道),该缺失会过早终止nef阅读框,而即使经过反复尝试,也无法从1992年的PBMC样本中扩增出nef基因。相比之下,vpr基因(来自1992年和1994年样本)显示出两种不同的准种,没有明显缺陷。我们在C末端83-90位氨基酸之间观察到五个氨基酸替换,最近有研究表明这与G2细胞周期停滞有关,是HIV-1感染的早期步骤。鉴于最近关于nef基因缺陷/衰减在HIV-1感染患者长期存活中的作用的证据,可能是基因重复导致的nef基因缺陷消除了二硫键形成中至关重要的半胱氨酸-206,这可能在该患者的慢性HIV-1感染中起作用。这些数据进一步表明,nef基因缺失可能不是某些个体HIV-1感染长期不进展的唯一原因,但nef和vpr基因功能基序中的基因重复和细微突变等基因缺陷可能在CD4计数稳定的情况下长期存活的HIV-1感染患者中提供类似的保护作用。